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Sensitivity to meat protein intake and hyperoxaluria in idio- Nephrolithiasis is a common source of morbidity in
pathic calcium stone formers. industrialized countries. Annual incidence is estimated
Background. High protein intake is an accepted risk factor at 1.3 per 1000 persons with a lifetime risk of 10 to 12%for renal stone disease. Whether meat protein intake affects
in men and 3 to 5% in women [1, 2]. The disease is atoxaluria, however, remains controversial in healthy subjects
least twice as frequent in whites than in blacks [3, 4] andand in stone formers. This study was designed (1) to test the
oxaluric response to a meat protein load in male recurrent most commonly appears between the fourth and the sixth
idiopathic calcium stone formers (ICSFs) with and without decade [1, 4].
mild metabolic hyperoxaluria (MMH and non-MMH, respec- Since Andersen’s observations [5], several studies havetively), as well as in healthy controls, and (2) to seek for possible
confirmed a strong relationship between stone prevalencedisturbed vitamin B6 metabolism in MMH, in analogy with
and affluence [6–9], thus linking nephrolithiasis to di-primary hyperoxaluria.
Methods. Twelve MMH, 8 non-MMH, and 13 healthy males etary factors [9–12]. Several authors observed a strong
were studied after five days on a high meat protein diet (HPD; correlation between intake of dietary animal protein and
700 g meat/fish daily) following a run-in phase of five days on nephrolithiasis [10, 13–15]. While it is generally accepted
a moderate protein diet (MPD; 160 g meat/fish daily). In both
that excess of dietary protein leads urinary excretion ofdiets, oxalate-rich nutrients were avoided, as well as sweeteners
lithogenic substances such as calcium [16–18] and uricand vitamin C-containing medicines. Twenty-four–hour uri-
nary excretion of oxalate was measured on the last day of acid [18, 19] to rise and excretion of citrate to fall [17],
each period, along with 4-pyridoxic acid (U4PA) and markers the role of animal protein intake on oxalate excretion
of protein intake, that is, urea, phosphate, uric acid, and sulfate. remains controversial. Evidence in some interventional
Serum pyridoxal 59 phosphate (SP5P) was measured after protein studies providing a protein load show an increase in uri-loading.
nary oxalate excretion [18, 20] or no increase [17, 21], or anResults. Switching from MPD (0.97 6 0.18 g protein/kg/day)
increase only in healthy females [22]. Similar discrepanciesto HPD (2.26 6 0.38 g protein/kg/day) led to the expected rise
in the urinary excretion rates of all markers of protein intake were found in protein restricted patients [23, 24]. The
in all subjects. Concurrently, the mean urinary excretion of controversy may reside in the fact that the populations
oxalate increased in ICSFs taken as a whole (173 6 134 mmol/ studied were heterogeneous and included various types24 h, P 5 0.024) as well as in the MMH subgroup (1100 6
of renal stone formers as well as healthy subjects. We144 mmol/24 h, P 5 0.034) but not in controls (217 6 63 mmol/
hypothesized that only specific groups of stone formers24 h). In seven ICSFs (4 MMH and 3 non-MMH) but in none
of the healthy controls (P 5 0.016, chi square), an increment such as patients with so-called mild metabolic hyperoxal-
in oxaluria was observed and considered as significant based uria (MMH) might be sensitive to meat protein in terms
on the intra-assay coefficient of variation at our laboratory of urinary oxalate excretion. The present study has been(8.5%). There was no difference in SP5P and U4PA between the carried out to test this hypothesis. It is an interventiongroups after protein loading.
study to compare the effect of a meat protein load onConclusion. Approximately one third of ICSFs with or with-
out so-called MMH are sensitive to meat protein in terms of urinary oxalate in three groups of subjects, that is,
oxalate excretion, as opposed to healthy subjects. Mechanisms healthy controls and idiopathic calcium stone formers
underlying this sensitivity to meat protein remain to be eluci- (ICSFs) with and without MMH. We also postulated
dated and do not seem to involve vitamin B6 deficiency. that, should this hypothesis be correct, an alteration in
vitamin B6 metabolism might underlie the observation,
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deficiency, metabolic hyperoxaluria, nephrolithiasis.
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Table 1. Subject characteristicsand December 1998, 73 recurrent ICSFs (defined by docu-
mented calcium-containing stones at infrared spectros- Controls All ICSF MMH Non-MMH
(N 5 13) (N 5 20) (N 5 12) (N 5 8)copy) were identified as potential candidates for the
Age years 53.268.7 54.369.6 52.8610.8 56.567.8study, that is, 43 with MMH and 30 with normal oxaluria,
BMI kg/m2 26.662.9 26.863.4 27.763.7 25.562.4this on the basis of three consecutive 24-hour urine col-
Number of
lections. MMH was defined as a urinary excretion rate stone passings 0 4.864.7a 5.365.6a 4.063.0a
of both oxalate and glycolate above 450 mmol/24 hours Abbreviations are in the Appendix.
a P , 0.0001 vs. controlson at least two of the three urine collections. Non-MMH
had to have an oxalate excretion below 450 mmol/24
hours in all three 24-hour urine collections. At that point,
a letter was sent to these patients inviting them to partici-
orally and in written form. Daily dietary records werepate in the study that was conducted between December
kept during the entire study to insure control of good1998 and April 1999. Male healthy subjects were invited
compliance, and the records were assessed with the helpto serve as controls by public announcement in newspa-
of PRODI 4.4, a software developed by the Section ofpers and internal posting.
Nutrition and Dietetics of the Department of MedicineTwenty-one stone formers volunteered for the study:
at the University of Freiburg (Freiburg, Germany).13 MMH and 8 non-MMH. From 30 healthy subjects
All participants were instructed to collect 24-hourwho also volunteered, 13 were finally selected after
urines (from 6 a.m. to 6 a.m.) over the last day on bothmatching for MMH patients’ age (65 years) and body
MPD and HPD into one or two plastic bottles (3 litersmass index (62 kg/m2) to serve as controls. One MMH
each) containing 10 g of boric acid as a preservativewithdrew before starting the trial because of self-limited
agent. Blood was drawn in fasting condition at the endunspecific abdominal discomfort.
of the study.Potential causes of urolithiasis (such as primary hyper-
parathyroidism, renal tubular acidosis, inflammatory
Measurements
bowel disease, medullary sponge kidney, sarcoidosis, vi-
Oxalate was measured using the oxalate oxidasetamin D intoxication, and urinary infection) had been
method [25]. In our hands, the mean intra-assay coeffi-excluded in previous work-ups. For control subjects, a
cient of variation (CV) for oxalate concentration, basedknown history of renal stone or any of the aforemen-
on duplicate measurements of two reference samplestioned conditions were exclusion criteria. All partici-
(Sigma Diagnostics, St. Louis, MO, USA), performed onpants were otherwise in good health, for example, they
16 different days was 8.5% for the low oxalate referencehad a normal clinical examination, transaminase activity,
urine and 6.0% for the high oxalate reference urine.and serum creatinine level, as well as no recent or present
Accuracy was good, with a mean value of 329 mmol/Lepisodes of diarrhea. All gave written informed consent
for the low oxalate reference urine (reference range fromto participate in this study, which had been approved by
manufacturer 5 250 to 370 mmol/L) and 925 mmol/L forthe Ethical Committee of the University of Berne, School
the high oxalate reference urine (reference range fromof Medicine (Berne, Switzerland).
manufacturer 5 850 to 1120 mmol/L).All subjects were given guidelines by a dietitian to
Urinary glycolate was measured by an enzymatic assayprepare their meals at home and were encouraged to
using glycolic acid oxidase extracted from spinach leavesfollow five different specified menus for both diets. They
[26], urinary citrate using the citrate lyase method [27],first underwent a five-day run-in period with moderate
and sulfate using the high-performance liquid chroma-animal protein intake (MPD), based on 160 g of lean
tography (HPLC) technique. Urea, calcium, phosphorus,meat or fish providing about 15% of total energy intake.
magnesium, sodium, potassium, chloride, and uric acidThen they were switched for five days to a high protein
were measured by autoanalyzer techniques. Vitamin B6diet (HPD), based on 700 g of lean meat or fish providing
metabolites were assayed using HPLC in serum (pyri-approximately 35% of total energy intake. As a conse-
doxal 59 phosphate, that is, the active metabolite of vita-quence of increased meat intake, the HPD contained
min B6) and urine (4-pyridoxic acid, that is, the excretion15% more fat and was designed to provide 42% less
product of B6).carbohydrates than MPD in order to secure identical
energy intakes. Both diets were restricted in oxalate and
Statisticshad a similar calcium content. During the entire test
Data are presented as mean 6 SD. Intergroup differ-period, participants were advised to abstain from taking
ences at baseline were tested using either nonparametricascorbic acid-containing medicines or sweeteners, and
tests or analysis of variance (ANOVA) according to thewere encouraged to drink more than usually in order to
distribution. Threshold value to accept a significant dif-produce at least 2000 mL urine/day. Diets were designed
to be taken at home, and instructions were given both ference between two consecutive values of a parameter,
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Table 2. Composition of the diets
Controls All ICSF MMH Non-MMH
Nutrient intake mean of 5 days Diet (N 5 13) (N 5 20) (N 5 12) (N 5 8)
Protein g/day MPD 75614 81613 84613 77612
HPD 184631c 191629c 201627c 172620bc
Protein energy/total energy % MPD 16.462.3 16.762.1 16.562.6 16.461.0
HPD 31.065.2c 30.563.4c 31.263.6c 29.363.0c
Fat g/day MPD 5768 64617 64616 63619
HPD 90621c 95613c 96615c 93610c
Carbohydrate g/day MPD 250659 265671 273677 251657
HPD 209681c 217655c 227653c 200657
Energy/body weight KCal/kg MPD 2363 2565 2566 2565
HPD 3166c 3265c 3266c 3264c
Calcium mg/day MPD 10286317 12456443 13366525 10906192
HPD 11856481 13126560c 13316582 12796562
Vitamin C mg/day MPD 1986155 115664a 124670 100654
HPD 137669 107657 121655 82656
Vitamin B6 mg/day MPD 1.660.5 1.460.5 1.460.5 1.360.4
HPD 2.960.5c 2.960.8c 3.160.9c 2.760.8c
a Significant vs. controls (P # 0.05)
b Significant vs. MMH (P # 0.05)
c Significant vs. MPD (P # 0.05)
Fig. 1. Individual and mean changes in uri-
nary oxalate excretion in controls and in idio-
pathic calcium stone formers (ICSFs) with or
without mild metabolic hyperoxaluria (MMH),
switching from a moderate protein (MPD) to
a high protein diet (HPD).
according to the CV of the method (CV%) is 1.96 3 tween the three groups, neither on MPD nor on HPD.
Protein intake was slightly lower on HPD in non-MMH=2 3 CV%. Thus, based on a CV of oxalate measure-
than in MMH; for those on a MPD, vitamin C intakement of 8.5%, the minimum difference between two
was larger in controls than in ICSFs. Switching fromconsecutive values of oxaluria in a patient to be signifi-
MPD to HPD led to an expectedly large increase incant is 23.6%. This does not mean, however, that such
protein intake and protein energy in all groups. Fat in-a difference is biologically relevant on an individual ba-
take increased by 50%, that is, much more than thesis, due to the large biological variability of oxaluria.
expected 15%, whereas carbohydrate decreased by only
17% compared with the planned 42%. As a consequence,
RESULTS total energy intake increased by 28%. These changes in
Table 1 summarizes the basal characteristics of all protein, fat, and carbohydrate intake were similar in all
study participants. There was no difference in age and groups. Such was also the case for the increase in vitamin
body mass index between the three groups. B6 intake in those switching from a MPD to HPD. Cal-
Table 2 summarizes the actual composition of both cium intake also increased slightly from the MPD to
diets, expressed as the mean value of the respective pa- HPD subjects, the change being significant in ICSFs only.
rameters recorded over five days. There was no differ- Figure 1 depicts individual and mean changes in oxa-
ence in energy/body weight, protein energy/total energy, late excretion in the three groups. No significant individ-
ual change was observed in controls, whereas four MMHcarbohydrate, fat, calcium, and vitamin B6 intake be-
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Table 3. Changes of urinary parameters switching from MPD to HPD
Controls All ICSF MMH Non-MMH
Urinary excretion Diet (N 5 13) (N 5 20) (N 5 12) (N 5 8)
Oxalate lmol/24h MPD 5156112 5116147 5576173 442655
HPD 498674 5846216c 6576229ac 4766147
Glycolate lmol/24h MPD 4996154 5766168 6336160a 4906149b
HPD 8046250c 883630c 9916288c 7216255bc
Urea mmol/24h MPD 4526101 4946119 5336124 435686
HPD 8516176c 8136203c 8856139c 7066244bc
Calcium mmol/24h MPD 5.663.7 8.764.0a 10.763.7a 5.761.9b
HPD 6.163.6 10.065.5ac 12.065.7a 7.163.8b
Sodium mmol/24h MPD 210649 216667 237666 186660
HPD 276687c 271671c 285663c 250680c
Sulfate mmol/24h MPD 23.567.7 25.569.9 28.5611.0 21.065.8
HPD 43.069.0c 39.6613.9c 44.0614.7c 33.0610.3bc
Phosphorus mmol/24h MPD 32.3610.3 37.6610.6 41.8610.9a 31.266.7b
HPD 45.4615.7c 47.2612.6c 51.5612.3c 40.8610.8c
Uric acid lmol/24h MPD 42976963 39016741 41926721 34646557a
HPD 655761797c 609361448c 673961052c 512361470abc
Citrate mmol/24h MPD 4.361.4 4.261.4 4.461.4 4.061.5
HPD 4.061.3 3.861.4c 4.061.2c 3.461.7
Magnesium mmol/24h MPD 6.561.6 6.762.3 7.562.1 5.462.0b
HPD 6.361.7 6.862.8 7.763.0 5.662.2
4-PA lmol/24h MPD 10.163.4 9.764.8 9.663.9 9.966.2
HPD 13.363.8c 11.364.1 12.064.0 10.364.2
Urine volume mL/24h MPD 30696584 26986989 31426884 20316762ab
HPD 32086515 294061165 342561141 22136792ab
a Significant vs. controls (P # 0.05)
b Significant vs. MMH (P # 0.05)
c Significant vs. MPD (P # 0.05)
and three non-MMH experienced a significant rise in colate and sulfate. For D-glycolate, there was a positive
urinary oxalate as defined in the Methods section. It correlation for both ICSFs and controls. For D-sulfate,
must be pointed out that 9 out of 13 controls and 2 out however, a significant correlation was found with D-oxa-
of 8 non-MMH on a MPD had 24-hour oxaluria levels late in ICSFs only, as was the case for D-urea (r 5 0.53,
over the normal range, whereas on that diet, 4 out of 12 P 5 0.02) and D-uric acid (r 5 0.59, P 5 0.005). There
MMH had normal oxaluria. were trends for similar correlations when separately con-
Table 3 summarizes biochemical urinary parameters: sidering MMH and non-MMH.
in groups on the MPD, urinary calcium and phosphorus Figure 3 depicts the individual values of serum pyri-
levels were significantly higher in MMH than in controls doxal-59-phosphate and urine 4-pyridoxic acid on HPD.
and non-MMH, respectively; as expected, glycolate was The pyridoxal 59 phosphate concentration was normal
higher in MMH than in non-MMH and controls. For in all subjects (normal range, 50 to 142 nmol/L) without
those on a HPD, urea, sulfate, uric acid, phosphorus, and a significant difference between the groups on average.
glycolate levels increased similarly in all groups versus However, subjects with the lowest four serum concentra-
MPD. Citrate fell on HPD in ISCFs as a whole and in tions of pyridoxal-59-phosphate and the lowest five uri-
MMH; a significance level, however, was not reached in nary outputs of 4-pyridoxic acid were all ICSFs.
controls and in non-MMH. As a consequence of in- In ICSF patients, there was a positive correlation be-
creased intake of vitamin B6 in subjects on a HPD versus tween serum concentration of pyridoxal-59-phosphate
MPD, urinary 4-pyridoxic acid increased slightly, the and urinary excretion rate of 4-pyridoxic acid. Such was
change being significant in controls only. On both diets, not the case in controls (Fig. 4). On the other hand, in
urine volume was in the order of 3 L/day in controls as controls, there was a strong negative correlation between
well as in ICSFs, which is substantially more than under oxaluria and serum concentrations of pyridoxal-59-phos-
normal conditions, as a consequence of encouragement phate, but this was not the case in ICSFs (Fig. 5).
to increase fluid intake during the study. Urine volume
was similar on both diets in the three groups. However,
DISCUSSIONnon-MMH subjects had a smaller urine volume than
This interventional study demonstrates that a diet pro-MMH or controls.
viding high amounts of protein derived from meat in-Figure 2 shows the regression analysis between
changes in urinary oxalate versus changes in urinary gly- duces an increased urinary oxalate excretion in recurrent
Nguyen et al: Meat protein intake in ICSF 2277
Fig. 2. Correlations between changes in urinary excretion of oxalate and changes in urinary excretion of glycolate or sulfate in controls and in
ICSFs. Symbols are: (s) ICSF subjects without MMH; (d) ICSF with MMH. In (A), r 5 0.55, P 5 0.05; in (B), r 5 0.50, P 5 0.03; in (C ) NS
(not significant); in (D), r 5 0.62, P 5 0.003.
calcium stone formers with or without mild MMH, but studies [6–9]. Excessive protein intake was rapidly postu-
lated to play a key role in this process [10, 13–15] becausenot in healthy subjects.
The link between dietary factors and nephrolithiasis it leads to urinary excretion of lithogenic substances such
as calcium [16–18] and uric acid [18, 19] to rise, andwas first suspected by Andersen back in the late 1960s [5]
and this finding was confirmed subsequently by several urinary excretion of citrate to fall [17].
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in six healthy males studied under a high protein diet,
whereas in six healthy females studied under similar con-
ditions, the urinary excretion rate of oxalate actually
rose by 20% [22]. In 12 ICSFs with absorptive hypercalci-
uria type II (7 males and 5 females), Urivetzky et al did
not observe any oxaluric effect of protein loading [21],
whereas a significant effect took place in 26 other stone
formers, most of them being uric acid stone formers
[20]. In eight ICSFs (7 males and 1 female), however,
Fellstro¨m et al did not find any change in oxalate excre-
tion after increasing their animal protein intake from 57 g
to 142 g/day [17].
The present study was designed to test the hypothesis
that only a subpopulation of ICSFs, that is, patients with
MMH, might be sensitive to meat protein loading in
terms of oxalate excretion. Actually, our evidence dem-
onstrates that protein loading leads to an oxaluric re-
sponse in one third of ICSFs, be they MMH or non-
MMH, but not in healthy controls. In fact, these results
raise the question of whether “MMH” would be an arti-
ficial entity, since we observed that not all control sub-
jects on a MPD had a normal urinary oxalate despite
their low oxalate intake, whereas 4 out of 12 MMH had
oxaluria in the normal range and 2 out of 8 non-MMH
had elevated oxaluria. Thus, the definition of hyperoxal-
uria may need to be revisited, especially since we are not
the only ones to observe a large overlapping of oxalate
excretion rates between healthy subjects and ICSFs [29].
In addition, oxaluria appears to vary widely over time,
at least in patients, and so-called MMH may correspond
to a transitory state. Urinary oxalate excretion and uri-
nary volume observed in controls on MPD were 1.6- and
2.2-fold higher than the respective values observed in
healthy subjects on a free-choice diet and usual fluid
intake in a previous study [30]. Increased urine volume
is interpreted as the consequence of encouragement to
drink, and the apparent hyperoxaluria observed in many
control subjects may just be the consequence of the high
fluid intake, since increased urinary oxalate excretion has
been shown to positively correlate to urinary volume [31].
If anything, one might argue that our findings should be
generalized to standard drinking conditions with caution.Fig. 3. Urinary excretion of 4-pyridoxic acid (B) and serum concentra-
Because all participants were on concurrent nutri-tion of pyridoxal-59-phosphate (A) in subjects on a high-protein diet
(HPD). Symbols are: (s) ICSFs with a significant HPD-induced rise tional oxalate restriction, increased oxalate excretion
in urinary oxalate excretion; (d) ICSF with normal urinary oxalate after protein loading observed in ICSFs most likely has alevels. Horizontal lines are the lower normal limits (percentile 2.5).
metabolic origin. Interference with vitamin C is unlikely,
based on the dietary records. We cannot definitely ex-
clude that the change in energy/carbohydrate/lipid con-Thus far, the role of high intake of protein on oxalate
excretion remains controversial, be it in healthy subjects tent between HPD and MPD did not influence oxaluria.
However, the slight decrement in carbohydrate intakeor in ICSFs. In six healthy male volunteers (not con-
trolled for oxalate ingestion), Robertson et al had ob- observed when switching from a MPD to HPD, if any-
thing, should have led oxaluria to decrease, not to in-served an increased excretion of oxalate following animal
protein loading [18], results that were not confirmed by crease, as discussed by a group of authors [32–34]. The
large fat intake on HPD can be suspected to increaseKok et al in 8 healthy males [28] studied a decade later.
Holmes et al also made such a negative observation oxaluria, that is, by binding calcium in the intestine and
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Fig. 4. Correlations between serum concen-
tration of pyridoxal-59-phosphate and urinary
excretion of 4-pyridoxic acid in controls (A)
and in ICSFs (B) on a high-protein diet (HPD).
Open circles represent ICSF without MMH,
and the bar across the circle indicates a sig-
nificant HPD-induced rise in urinary oxalate
excretion. In (A), r 5 20.26, P 5 0.39; in (B),
r 5 0.48, P 5 0.03.
Fig. 5. Correlations between urinary oxalate
excretion and serum concentration of pyri-
doxal-59-phosphate in controls (A) and in
ICSFs (B) on a high-protein diet (HPD).
Open circles represent ICSF without MMH,
and the bar across the circle indicates a sig-
nificant HPD-induced rise in urinary oxalate
excretion. In (A), r 5 0.69, P , 0.01; in (B),
NS (not significant).
thus favoring intestinal overabsorption of oxalate. In- serum concentration of pyridoxal 59 phosphate (the ac-
tive moiety of vitamin B6) and urinary excretion rate ofdeed, Masai, Ito, and Kotake found a positive correlation
between fat intake and oxaluria in 60 patients [35]. How- 4-pyridoxic acid (the excretion product of vitamin B6)
both were normal in these patients, thus at first glanceever, Bailly, Norman, and Thompson could not find such
a relationship in a much larger population of 476 calcium in these cases excluding an impaired conversion of pyri-
doxin into its active metabolite, as well as a pyridoxinstone formers [36]. Moreover, it is unlikely that increas-
ing fat intake would lead oxaluria to rise only in ICSFs deficiency or malabsorption. Looking more carefully at
the data, however, it appears that in 25% of ICSFs, urinaryand not in controls.
Other arguments for a protein related oxaluric effect excretion of 4-pyridoxic acid was lower than the lowest
value observed in the control population. Moreover, inare the correlations between changes in oxaluria and
changes in excretion of the urinary markers of protein these patients, there was a positive correlation between
serum pyridoxal 59 phosphate and urinary 4-pyridoxicintake. The fact that these correlations were only present
in ICSF actually supports the contention of a rather acid, thus pointing to the functional significance of the
relative vitamin B6 deficiency seen in this fraction of“exclusive” pro-oxaluric effect of proteins in ICSF. In
this regard, it is noteworthy that urinary glycolate also ICSF. The fact that in controls a tight and negative corre-
lation took place between urinary oxalate and serumappears to be an indirect marker of protein intake or,
more specifically, a marker of meat protein intake, as this pyridoxal 59 phosphate further supports the relationship
between the vitamin B6 status of an individual and itscould have actually been anticipated from the glyoxylate
pathway portrayed in Figure 6. oxalate excretion rate. That this relationship was abol-
ished in ICSFs further illustrates the fact that vitaminWe could not find any specificity of the seven patients
with positive oxaluric response to meat protein loading: B6 metabolism is disturbed in the hyperoxaluric patients
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Fig. 6. Metabolic pathways from meat proteins to oxalate. Shaded circles correspond to various enzymes: AGT, alanine-glyoxylate aminotransferase;
GR, glyoxylate reductase; GO, glycolate oxidase; LDH, lactate dehydrogenase. AGT deficiency causes type 1 primary hyperoxaluria, where
glyoxylate cannot be metabolized to glycine, leading both glycolate and oxalate to accumulate. Vitamin B6 supplementation may partially or
completely correct the metabolic disorder.
taken collectively compared with the control population In conclusion, about one third of ICSFs, with or with-
out MMH, are sensitive to meat protein in terms of(unpublished observation). This, in turn, may account, at
least in part, for protein sensitivity and/or hyperoxaluria oxalate excretion, and this response to meat protein
observed in a substantial fraction of patients with so- could be a more meaningful criterion to define a sub-
called idiopathic calcium oxalate stone formation. group of stone formers than so-called MMH. The precise
The present study suggests, however, that other mech- mechanisms underlying this sensitivity remain to be elu-
anisms have to be evoked to account for this sensitivity cidated and do not seem to involve vitamin B6 deficiency.
to meat protein in terms of urinary oxalate. Some of them In theory, protein load might be proposed as a test to
might be related to increased activity of the enzymes identify patients with a clear oxaluric response who might
involved in the metabolic pathway from hydroxyproline optimally benefit of meat protein restriction. In fact,
or tryptophane to oxalate (Fig. 6). Indeed, these path- curtailing an excessive protein intake also confers the
ways are influenced by many factors. In rats, for instance, advantage of reducing uric acid and calcium excretion
testosterone promotes the activity of glycolate oxidase and of raising citrate excretion. Therefore, this dietary
[37], and insulin, glucagon, glucocorticosteroids, and thy- measure should still be widely recommended.
roid hormone are possible inducers of oxalate synthesis
[22]. Thus, an unsuspected endocrine disorder might un- ACKNOWLEDGMENTS
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